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under the receiver operating characteristic (ROC) curve was
calculated. In 6249 of 6405 (97.6%) pts. survival status was known
and in 5413 (86.6%) pts a complete data set was available. The same
methods were then applied in 2317 ta-TAVR pts with a complete data
set.
RESULTS In tv-TAVR 30dm was 5.7%. Based on multiple logistic
regression, 15 risk factors impacting mortality were identiﬁed
including age, COPD, bicuspide aortic valve and others. The area un-
der the ROC curve with a value of 0.69 afﬁrmed the quality of
discrimination of the established scoring model. The model was then
tested prospectively on 3920 pts with full data set treated in the year
2013. Slightly less 30dm was observed than predicted in the very high
risk pts reﬂecting medical progress 2013 versus 2011/2012. In ta-TAVR
30dm was 8.5%, 13 risks factors partly different from transvascular pts
were identiﬁed and then prospectively tested. Some misalignment
between observed and predicted mortality could be demonstrated,
reﬂecting signiﬁcant inﬂuence of the ta-TAVR procedure outside pts
inherited risks.
CONCLUSIONS Based on GARY data the above models allows the
prediction of TAVR operative risks. Risk factors between tv- and ta-
TAVR deviate and risk prediction should be evaluated separately.
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BACKGROUND Transcatheter aortic valve implantation (TAVI) is
mainly done via a conventional strategy (CS); i.e., under general
anesthesia (GA) in hybrid operating rooms with transesophageal Echo
(TEE) guidance. Some centers, mostly in Europe, have demonstrated
the feasibility of a minimally invasive strategy (MIS); i.e., under local
anesthesia and conscious sedation without TEE guidance. Nonethe-
less, the experience of MIS for TAVI is largely limited in the United
States. Herein, we describe the evolution of an academic, high volume
TAVI program using either self- or balloon-expandable valves and its
transition from a CS to a MIS.
METHODS We, retrospectively, studied all transfemoral TAVI cases
with both commercially available self-expandable and balloon
expandable valves done at our institution between March 2011 and
November 2014. Patients were dichotomized according to the strategy
(MIS and CS). In-hospital, 30-day outcomes, gross cost data, and
midterm survival were evaluated.
RESULTS One hundred and sixteen patients were included in the MIS
group and 91 patients were included in the CS group. Baseline char-
acteristics were similar between groups. Procedural success was
comparable (99.1 % in MIS and 98.9 % in CS, p¼1). One intraprocedural
death occurred in each group. Conversion rate to GA was low (3.4%).
Length of hospital stay was signiﬁcantly reduced in the MIS (median
3.0 days [2.0,5.0]) compared to CS group (median 6.0 days [3.5,8.0]).
Complication rates were low and comparable between groups. Thirty-
day mortality and 30-day stroke/ transient ischemic attack rates were
similar (4.3% vs 4.4%; p¼1 and 0.9% vs 1.1%; p¼0.45, respectively). At
median follow up of 230 days, no signiﬁcant difference in survival was
detected (89 % vs. 88 %, p¼0.9). MIS was associated with cost saving
compared to CS (16000 $/case).
CONCLUSIONS This is the largest comparison between a MIS and a CS
for TAVI performed in the United States. TAVI via MIS was associated
with a shorter postprocedural hospital stay, lower hospital costs, and
similar safety proﬁle while keeping procedural efﬁcacy as compared to
CS.
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BACKGROUND New-onset conduction delays are one of the most
frequent complications after transcatheter aortic valve implantation
(TAVI). The purpose of this study was to evaluate the incidence of
new-onset intraventricular delays after TAVI with Edwards Sapien
aortic valves implantation.
METHODS A total of 136 consecutive patients undergoing TAVI with
Edwards Sapien aortic valves were included into a single-center
perspective registry between August 2011 and April 2015; 106 patients
received Edwards Sapien valves and 30 patients received Edwards Sapien
3 valves. Intraventricular conduction delays – deﬁned as right or left
bundle branch block – were assessed on ECGs acquired before TAVI,
immediately after TAVI, 24 hours after TAVI, and before discharge.
RESULTS The incidence of new-onset intraventricular conduction
delays was higher in patients treated with the Edwards Sapien 3 valve
as compared to those treated with the Edward Sapien valve (46.6% vs.
18.8%, P¼0.004). However, in 46% of patients treated with the
Edward Sapien 3 valve intraventricular conduction delays were tran-
sient, with complete resolution at discharge. No difference was
observed between patients treated with the Edwards Sapien 3 valve
and those treated the Edward Sapien valve in terms of deﬁnitive
pacemaker implantation after TAVI (10.7% vs 14.2%, P¼0-76).
CONCLUSIONS TAVI with new-generation Edwards Sapien 3 valve
might be associated with an increased risk of new-onset intraventricular
conduction delays. The latter, however, appears to be transient and not to
correlate with an increased risk of deﬁnitive pacemaker implantation.
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BACKGROUND Previous studies have demonstrated that a high neutro-
phil to lymphocyte ratio (NLR) is amarker of inﬂammation andprogression
of atherosclerosis. NLR has also been shown to be signiﬁcantly elevated in
patientswith severe calciﬁc aortic stenosis.However, prognostic relevance
of highNLR in patients undergoingTranscatheter aortic valve replacement
(TAVR) on operative mortality is not clearly deﬁned.
METHODS We retrospectively evaluated 166 consecutive patients
undergoing TAVR at our institution between 2012 and 2014. Baseline
characteristics, 30 day major adverse cardiovascular events (MACE),
deﬁned as composite end point of stroke, myocardial infarction, car-
diovascular death or re-hospitalization, and 30 day all-cause mortality
were analyzed. NLR was calculated as ratio of absolute neutrophil
count to absolute lymphocyte count, prior to TAVR procedure.
RESULTS The mean ( SD) total white blood cell, absolute neutrophil
and lymphocyte counts were 6.8 ( 1.8) x 103/mL, 4.6 (1.6) x 103/mL and
1.2 (0.5) x 103/mL, respectively. The mean ( SD) NLR was 4.5 ( 2.5).
NLR was signiﬁcantly correlated with pulmonary artery systolic pressure
(r ¼ 0.23, p ¼ 0.008) and society of thoracic society (STS) score (r ¼ 0.21,
p ¼ 0.02). ). On multivariate cox regression survival analysis, after
adjusting for age, gender, ethnicity, STS score, left ventricular ejection
fraction, pulmonary artery systolic pressure, history of diabetes mellitus,
peripheral vascular and cerebrovascular disease, patients with a NLR > 4
had signiﬁcantly reduced survival at 30 days when compared to those
with NLR < 4 (83.6% vs. 95.6%, hazard ratio (HR) 4.23, 95% conﬁdence
interval (CI): 1.04 to 17.26, p ¼ 0.04).
